Ark Biotech
PrivateLast Round
Grant
Aug 14, 2025
Total Funding Raised
$16.88M
Company Overview
Ark Biotech is a biotechnology company that develops high-fidelity bioprocess simulation software to optimize cell culture processes and scale production.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Vertical SaaS, Drug Discovery
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Ark Biotech Comparables
Compare Ark Biotech with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| BioReact | 87% | |
| PolyModels Hub | 85% | |
| DataHow AG | 84% |
Ark Biotech Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Aug 14, 2025 | ||||
| Series A | May 24, 2024 | ||||
| Seed | May 3, 2022 | ||||
| Seed | Dec 1, 2021 |
Key People
Founding team and executive leadership
Ark Biotech Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| F4 Fund | Seed |
| The Engine | Series A, Seed |
| Hawktail Management | Seed |
| Public Health Emergency Medical Countermeasures Enterprise | Grant |
| HCVC | Series A, Seed |
| BioTools Innovator | Grant |
| Lowercase Capital | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 12, 2025
Monthly visitors increased 274% MoM, from 82 to 307.
- Aug 14, 2025
$200K grant from BioTools Innovator and PHEMCE.
Ark Biotech Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Ark Biotech's valuation, stock price, and market status.
Is Ark Biotech a public or private company?
Ark Biotech is a private company.
What is the current stock price of Ark Biotech?
Ark Biotech is a private company with no public stock price. No recent secondary market data is available.
How much is Ark Biotech worth (valuation)?
Valuation information for Ark Biotech is not publicly available.
Can I buy Ark Biotech stock?
Ark Biotech shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Ark Biotech's last funding round?
Ark Biotech's most recent funding round was Series A on May 24, 2024.
Who are the main investors in Ark Biotech?
Key investors in Ark Biotech include The Engine, HCVC.
Will Ark Biotech IPO soon?
No public IPO plans have been announced for Ark Biotech.
How can I track Ark Biotech secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Ark Biotech's secondary market activity and sign up for updates.